High prevalence of fluoroquinolone‐resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018–2020

BACKGROUND: Uropathogen resistance, fluoroquinolone‐resistance (FQR), and extended spectrum beta‐lactamase (ESBL), has been observed to be emerging worldwide with prevalences above recommended thresholds for routine empirical treatment. The primary aim of our study was to determine the prevalence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Faine, Brett A., Rech, Megan A., Vakkalanka, Priyanka, Gross, Alan, Brown, Caitlin, Harding, Stephanie J., Slocum, Giles, Zimmerman, David, Zepeski, Anne, Rewitzer, Stacey, Howington, Gavin T., Campbell, Matt, Dawson, Jordan, Treu, Cierra N., Nelson, Lucas, Jones, Mandy, Flack, Tara, Porter, Blake, Sarangarm, Preeyaporn, Mattson, Alicia E., Bailey, Abby, Kelly, Gregory, Talan, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543902/
https://www.ncbi.nlm.nih.gov/pubmed/35652493
http://dx.doi.org/10.1111/acem.14545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543902/
https://www.ncbi.nlm.nih.gov/pubmed/35652493
http://dx.doi.org/10.1111/acem.14545

Ejemplares similares